REQUEST A DEMO
Total
USD $0.00
Search more companies

Orthos Pharma SIA (Latvia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Orthos Pharma SIA Profile Updated: May 24, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Russian Download a sample report

Orthos Pharma SIA is a company based in Latvia, with its head office in Riga. The enterprise operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. It was first established on December 02, 2014. The total number of employees is currently 22 (2023). The company’s latest financial report indicates a net sales revenue increase of 30.49% in 2024. A growth of 22.85% was recorded in its total assets. The enterprise’s net profit margin increased by 1.67% in 2024.

Headquarters
Ozolciema iela 18 - 338
Riga; Riga; Postal Code: 1058

Contact Details: Purchase the Orthos Pharma SIA report to view the information.

Website: https://www.orthospharma.com/eng.html

Basic Information
Total Employees:
Purchase the Orthos Pharma SIA report to view the information.
Registered Capital:
Purchase the Orthos Pharma SIA report to view the information.
Financial Auditors:
Purchase the Orthos Pharma SIA report to view the information.
Incorporation Date:
December 02, 2014
Key Executives
Purchase this report to view the information.
Member of Management Board
Purchase this report to view the information.
Member of Management Board
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Orthos Pharma SIA report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
30.49%
Total Operating Revenue
34.02%
Operating Profit
85%
EBITDA
85%
Net Profit/Loss for the Period
85%
Total Assets
22.85%
Total Equity
31.47%
Operating Profit Margin
1.67%
Net Profit Margin
1.67%
Return on Equity (ROE)
6.93%
Quick Ratio
0.53%
Cash Ratio
-0.01%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?